Malin Corporation | MLC - Operating Expenses


Malin Corporation reported EUR1.1M in Operating Expenses for its fiscal semester ending in December of 2024.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 1.19M 148K Sep/2025
ALKERMES USD 326.44M 1.41B Dec/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Dianthus Therapeutics USD 69.82M 29.14M Dec/2025
Eurofins Scientific SE EUR 3.29B 462.3M Dec/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Lonza CHF 2.9B 184M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Moderna USD 1.54B 259M Dec/2025
Organon & Co USD 906M 362M Sep/2025
Ovoca Bio EUR 1.16M 4.48M Jun/2025
Revvity USD 626.22M 25.62M Dec/2025
Tectonic Therapeutic USD 21.52M 374K Dec/2025
Viatris USD 3.86B 335.7M Dec/2025
Xeris Pharmaceuticals USD 69.03M 1.38M Dec/2025